LAVA Medtech Acquisition Corp. (Nasdaq: LVAC) is a blank-check company formed to pursue a business combination in the medical technology sector. Sponsored by LAVA Medtech Acquisition Holdings LLC, the company completed its initial public offering in 2021 and has been engaged in target identification since that time. The 10-Q filing submitted on May 16, 2022, reflects the company's status as a pre-combination SPAC operating within the healthcare and medtech space, a sector that attracted significant SPAC activity during that period. LVAC represents the growing cohort of medtech-focused acquisition vehicles seeking to bring private healthcare innovation companies to public markets. Visit SpacDesk and sign up for full data, filings, and deal tracking on LVAC and hundreds of other active SPACs.